Old Web
English
Sign In
Acemap
>
Paper
>
Long-term efficacy and safety of lanadelumab by baseline attack rates in hereditary angioedema
Long-term efficacy and safety of lanadelumab by baseline attack rates in hereditary angioedema
2021
Aleena Banerji
Marc A. Riedl
Raffi Tachdjian
Christina Nurse
Ming Yu
Sorena Kiani
Keywords:
Dermatology
Medicine
Lanadelumab
Hereditary angioedema
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]